2,2,2-trifluoroethanesulfonyl chloride has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Begent, RH; Boden, JA; Boden, R; Chester, KA; Delgado, C; Fisher, D; Francis, GE; Herraez, A; Keep, PA; Pedley, RB | 1 |
1 other study(ies) available for 2,2,2-trifluoroethanesulfonyl chloride and Adenocarcinoma
Article | Year |
---|---|
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Binding Sites, Antibody; Biological Availability; Carcinoembryonic Antigen; Colonic Neoplasms; Female; Humans; Immunoglobulin Fab Fragments; Linear Models; Mice; Mice, Nude; Neoplasm Transplantation; Polyethylene Glycols; Recombinant Fusion Proteins; Sulfones; Tissue Distribution | 1996 |